12/4
08:05 am
kalv
KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
High
Report
KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
12/4
05:48 am
kalv
Rating for KALV
High
Report
Rating for KALV
12/4
05:48 am
kalv
Rating for KALV
High
Report
Rating for KALV
11/11
07:03 am
kalv
KalVista Pharmaceuticals (NASDAQ:KALV) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
KalVista Pharmaceuticals (NASDAQ:KALV) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
9/12
09:57 am
kalv
KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Low
Report
KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
9/12
09:37 am
kalv
Rating for KALV
Low
Report
Rating for KALV
9/12
09:37 am
kalv
Rating for KALV
Low
Report
Rating for KALV
9/12
07:03 am
kalv
Rating for KALV
Medium
Report
Rating for KALV
9/12
07:03 am
kalv
Rating for KALV
Medium
Report
Rating for KALV